Latest News

Researchers discover origin of resistance to lung cancer

For treating cancer, drugs based on molecules known as tyrosine kinase inhibitors are sometimes used. One such tyrosine kinase inhibitor, called osimertinib, has been used to treat EGFR-mutated lung cancer with a certain degree of efficacy.

Source link

Related posts

Heart Patients Pay the Price When Nearby Pharmacy Closes


Medical News Today: How to burn fat if you cannot workout


Vaccine drama on display in California’s Capitol


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy